Cargando…

Sex Differences in Taxane Toxicities

SIMPLE SUMMARY: Clinically observed sex differences in acute and long-term taxane chemotherapy-induced normal tissue toxicity are routinely documented but remain poorly understood despite the significant impact such toxicities have on treatment tolerance and quality of life outcomes in cancer surviv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chmielewski, Nicole N., Limoli, Charles L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317669/ https://www.ncbi.nlm.nih.gov/pubmed/35884386 http://dx.doi.org/10.3390/cancers14143325

Ejemplares similares

Sex-Specific Differences in Toxicity Following Systemic Paclitaxel Treatment and Localized Cardiac Radiotherapy
por: Chmielewski-Stivers, Nicole, et al.
Publicado: (2021)

Natural Taxanes: From Plant Composition to Human Pharmacology and Toxicity
por: Nižnanský, Ľuboš, et al.
Publicado: (2022)

Mechanisms of Taxane Resistance
por: Maloney, Sara M., et al.
Publicado: (2020)

The taxanes: toxicity and quality of life considerations in advanced ovarian cancer
por: Guastalla III, J P, et al.
Publicado: (2003)

Taxane-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2015)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

Assessment of Pharmacogenomic Panel Assay for Prediction of Taxane Toxicities: Preliminary Results
por: Di Francia, Raffaele, et al.
Publicado: (2017)

Taxanes for the Treatment of Metastatic Breast Cancer
por: Gradishar, W.J.
Publicado: (2012)

Taxanes in the Treatment of Advanced Gastric Cancer
por: Kang, Byung Woog, et al.
Publicado: (2016)

Disposition Kinetics of Taxanes in Peritoneal Dissemination
por: Miyamoto, Ken'ichi, et al.
Publicado: (2012)

Impact of taxanes on androgen receptor signaling
por: Bai, Shanshan, et al.
Publicado: (2019)

Taxanes in the elderly patient with metastatic breast cancer
por: Yardley, Denise A
Publicado: (2015)

Platinum drugs and taxanes: can we overcome resistance?
por: Sazonova, Elena V., et al.
Publicado: (2021)

P-gp and taxanes
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2014)

Beyond taxanes: the next generation of microtubule-targeting agents
por: Cortes, Javier, et al.
Publicado: (2011)

Update on taxane development: new analogs and new formulations
por: Yared, Jean A, et al.
Publicado: (2012)

Long Noncoding RNAs in Taxane Resistance of Breast Cancer
por: Chen, Hailong, et al.
Publicado: (2023)

Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Hsieh, Ching-Yun, et al.
Publicado: (2023)

Docetaxel: an alternative taxane in ovarian cancer
por: Katsumata, N
Publicado: (2003)

Taxane-induced acute interstitial pneumonitis in patients with breast cancer and outcome of taxane rechallenge
por: Anoop, T M, et al.
Publicado: (2022)

Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
por: Kianersi, Shirin, et al.
Publicado: (2023)

Breast Cancer: Clinical–Epidemiological Profile and Toxicities of Women Receiving Treatment with Taxanes in the Amazon Region
por: Costa, Marta Solange Camarinha Ramos, et al.
Publicado: (2023)

Low Intensity Ultrasound as an Antidote to Taxane/Paclitaxel-induced Cytotoxicity
por: Amaya, Celina, et al.
Publicado: (2022)

Gemcitabine and taxanes in metastatic breast cancer: a systematic review
por: Gudena, Vinay, et al.
Publicado: (2008)

The role of taxanes in triple-negative breast cancer: literature review
por: Mustacchi, Giorgio, et al.
Publicado: (2015)

Current Perspectives on Taxanes: Focus on Their Bioactivity, Delivery and Combination Therapy
por: Škubník, Jan, et al.
Publicado: (2021)

Persistent oxidative stress in human neural stem cells exposed to low fluences of charged particles
por: Baulch, Janet E., et al.
Publicado: (2015)

Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer
por: van Eerden, Ruben A G, et al.
Publicado: (2020)

A randomised controlled trial of interventions for taxane-induced nail toxicity in women with early breast cancer
por: Morrison, Audrey, et al.
Publicado: (2022)

ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy
por: Zhong, Jia, et al.
Publicado: (2019)

Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
por: Bumbaca, Brandon, et al.
Publicado: (2018)

Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment
por: Vergote, Ignace, et al.
Publicado: (2023)

Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
por: Rivera, Edgardo, et al.
Publicado: (2015)

Sex differences in drug effects and/or toxicity in oncology
por: Rakshith, H.T., et al.
Publicado: (2023)

Scalable, enantioselective taxane total synthesis
por: Mendoza, Abraham, et al.
Publicado: (2011)

Taxane-Induced Upper Gastrointestinal Bleeding
por: Liu, Yao, et al.
Publicado: (2021)

Hypersensitivity Reactions to Platinum Agents and Taxanes
por: Tsao, Lulu R., et al.
Publicado: (2021)

Structural insight into the stabilization of microtubules by taxanes
por: Prota, Andrea E, et al.
Publicado: (2023)

Optimal use of taxanes in metastatic breast cancer
por: King, K.M., et al.
Publicado: (2009)

A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
por: Sohn, Eun Hee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_14e0vgfsbis82hc706fo7b6s3j